WCPO: UC scientist finds new solution to fight superbug infections
Professor Hassett takes on some of the nastiest infections resistant to antibiotics
Journalist Paulo Suro speaks with Daniel Hassett, PhD, professor in the UC Department of Molecular Genetics, Biochemistry and Microbiology, about his patented treatment AB569 and its possible use to treat cystic fibrosis, chronic obstructive pulmonary disease and other infections. AB569 tackles some of the nastiest superbugs on the planet and currently being tested in human trials to ensure its safety for future patients.
Related Stories
What is neuro-symbolic AI?
July 2, 2026
Neuro-symbolic AI blends pattern recognition with logical reasoning, creating a new form of artificial intelligence that could play a guiding role in the future of business, healthcare and robotics.
David Gius, MD, PhD, officially takes the helm as director of the University of Cincinnati Cancer Center
July 1, 2026
David Gius, MD, PhD, officially takes the helm as director of the University of Cincinnati Cancer Center, bringing a bold vision for elite cancer care.
UC lands $3.3M grant to study microplastics' effects on cardiovascular health
June 30, 2026
Microplastics are everywhere, including in the clothes we wear, the food we eat and the water we drink. Scientists at the University of Cincinnati received a grant worth more than $3 million to study the effects of microplastics on heart health. They recently appeared on WLWT-TV/Ch. 5 to discuss their groundbreaking research.